This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Susic, D. Articles by Frohlich, E. D. Search for Related Content PubMed PubMed Citation Articles by Susic, D. Articles by Frohlich, E. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB LISINOPRIL SPIRONOLACTONE Social Bookmarking                         What's this?

Beneficial Cardiovascular Actions of Eplerenone in the Spontaneously Hypertensive Rat

Hypertension Research Laboratory, Division of Research, Ochsner Clinic Foundation, New Orleans, LA

Jasmina Varagic, MD, PhD

Hypertension Research Laboratory, Division of Research, Ochsner Clinic Foundation, New Orleans, LA

Jwari Ahn, MD

Hypertension Research Laboratory, Division of Research, Ochsner Clinic Foundation, New Orleans, LA

Luis C. Matavelli, MD

Hypertension Research Laboratory, Division of Research, Ochsner Clinic Foundation, New Orleans, LA

Edward D. Frohlich, MD

Hypertension Research Laboratory, Division of Research, Ochsner Clinic Foundation, New Orleans, LA

Background: Aldosterone has been implicated as a potential mediator of cardiac and vascular damage in a variety of disorders. This study examined the role of aldosterone and its interplay with the renin-angiotensin system in the pathogenesis of hypertension. To this end, the effects of the aldosterone antagonist eplerenone and the angiotensin converting enzyme inhibitor lisinopril on cardiovascular mass, myocardial collagen, and coronary circulation were examined in spontaneously hypertensive rats.

Methods: Male, 22-week-old rats were randomly divided into 4 groups (12 in each). The control group received no treatment, the second group was given eplerenone (100 mg/kg/day), the third received lisinopril (3 mg/kg/day), and the fourth was given eplerenone and lisinopril. After 12 weeks of respective treatments, systemic and regional hemodynamics and cardiovascular mass indexes were measured in conscious instrumented rats.

Results: Eplerenone decreased arterial pressure but did not affect left ventricular mass or hydroxyproline concentration (an estimate of collagen). It did, however, reduce minimal coronary vascular resistance and increased coronary flow reserve. Lisinopril decreased arterial pressure and ventricular mass but did not affect regional hemodynamics. The combination therapy produced synergistic effects.

Conclusion: Aldosterone antagonism improved coronary and systemic hemodynamics in adult spontaneously hypertensive rats but did not affect cardiovascular mass indexes. The finding that lisinopril and eplerenone decreased arterial pressure to the same extent but had different cardiovascular effects suggested that these effects might be pressure independent.

Key Words: aldosterone • myocardial fibrosis • coronary hemodynamics • lisinopril

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 10, No. 3, 197-203 (2005)
DOI: 10.1177/107424840501000308


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Matsui, K. Ando, H. Kawarazaki, A. Nagae, M. Fujita, T. Shimosawa, M. Nagase, and T. Fujita Salt Excess Causes Left Ventricular Diastolic Dysfunction in Rats With Metabolic Disorder Hypertension, August 1, 2008; 52(2): 287 - 294. [Abstract] [Full Text] [PDF]

				D. Susic, J. Varagic, J. Ahn, L. Matavelli, and E. D. Frohlich Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H175 - H179. [Abstract] [Full Text] [PDF]